Jan Erik Alenfall

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.

Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark.

Part of Lantmännen ek för, Lantmännen AS-Faktor AB is a company based in Stockholm, Sweden. The Swedish company provides scientific and technical research and development services.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Siguiente Capital AB is a Swedish company that offers administration and corporate services to clients worldwide. The private company is based in Vaxholm, Sweden, and has subsidiaries in Sweden. Siguiente Capital was founded in 1981, and the CEO is Torbjörn Nordberg. The company specializes in administrating Swedish holding companies and providing efficient corporate tax planning advice.

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden.

The Local Europe AB operates as a holding company with interest in engaging in the publication of Swedish and German news and information to English language. It also deals with the sale of advertising space and other related activities. The company was founded by Paul Louis Rapacioli and James William Savage in 2004 and is headquartered in Stockholm, Sweden.

Pharmaorigin ApS is a holding company that provides medical treatment. It offers medication for prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia. The company was founded by Lars Heslet on November 14, 2005 and is headquartered in H?rsholm, Denmark.

The Swedish-American Chamber of Commerce, Inc. is a business organization that provides contacts, partners, and business services to help businesses succeed in the United States. The non-profit company is based in New York, NY, with its office located at 900 3rd Avenue, 29th floor. The chamber offers memberships, marketing opportunities, and events and programming, including the largest transatlantic meet up for female leaders, entrepreneurs, and investors. With over 70 events and three large conferences arranged every year, the chamber's calendar most likely includes the right events for all business needs.

Fredrik Buch Konsult AB provides consultancy services. The company is headquartered in Bromma, Sweden.

Huvudsta Vårdcentral AB operates a health care center. Huvudsta Vårdcentral AB is based in Solna, Sweden.

LobSor Holding AB owns and manages shares and participations. The company is headquartered in Uppsala, Sweden.

CytoVac AS manufactures pharmaceuticals. The private company is based in Hørsholm, Denmark. The Danish company was founded in 2008. The CEO is Lone Dahl Andersen.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Bonvisi AB provides medical devices for the endoscopic market. Its products include Endo P, Day cassette, Patient Cassette, irrigation tube, accessories, Endo H and EBI. The company was founded by Anders Gunnar Mollstam in 2013 and is headquartered in Nacka, Sweden.

Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

Part of Nidda Topco SARL, Lobsor Pharmaceuticals AB is a Swedish company that manufactures and wholesales pharmaceutical products. The company is based in Uppsala, Sweden. The company was founded by Ulf Rosén, who has been the CEO since incorporation. Lobsor Pharmaceuticals was acquired by STADA Arzneimittel AG, a subsidiary of Nidda Topco SARL from LobSor Holding AB on October 02, 2020.

Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021.

InTrance Holding AB is an investment holding Swedish company. The company is based in Uppsala, Sweden. The company was founded in 2018 by Ulf Rosén.

Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.